ORAGEN-C Trademark

Trademark Overview

On Friday, July 21, 2017, a trademark application was filed for ORAGEN-C with the United States Patent and Trademark Office. The USPTO has given the ORAGEN-C trademark a serial number of 79218450. The federal status of this trademark filing is REGISTERED as of Tuesday, January 29, 2019. This trademark is owned by Pacific Pharmaceuticals Pte Ltd. The ORAGEN-C trademark is filed in the Pharmaceutical Products category with the following description:

Mineral dietary supplements for humans containing Vitamin C; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations containing Vitamin C for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases
oragen-c

General Information

Serial Number79218450
Word MarkORAGEN-C
Filing DateFriday, July 21, 2017
Status700 - REGISTERED
Status DateTuesday, January 29, 2019
Registration Number5663319
Registration DateTuesday, January 29, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesMineral dietary supplements for humans containing Vitamin C; pharmaceutical drugs, namely, antipyretics, anti-infectives, antineoplastics, diuretics, and pharmaceutical preparations containing Vitamin C for the treatment of immune system disorders, disorders of the central nervous system, endocrine disorders, gastrointestinal diseases, dermatological diseases, infectious diseases, cardiovascular diseases, and respiratory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePacific Pharmaceuticals Pte Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSingapore 069533
SG
Party NamePacific Pharmaceuticals Pte Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 069533
SG
Party NamePacific Pharmaceuticals Pte Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 069533
SG

Trademark Events

Event DateEvent Description
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 7, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 22, 2019FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 22, 2019FINAL DISPOSITION PROCESSED
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Friday, November 9, 2018NOTIFICATION PROCESSED BY IB
Wednesday, October 24, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 24, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 18, 2018SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, September 18, 2018ASSIGNED TO LIE
Tuesday, February 20, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, February 20, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, February 20, 2018SUSPENSION LETTER WRITTEN
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 17, 2017REFUSAL PROCESSED BY IB
Friday, October 27, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 27, 2017REFUSAL PROCESSED BY MPU
Tuesday, October 24, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 24, 2017APPLICATION FILING RECEIPT MAILED
Monday, October 23, 2017NON-FINAL ACTION WRITTEN
Friday, October 20, 2017ASSIGNED TO EXAMINER
Wednesday, October 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 12, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

oragen diseases disorders pharmaceutical vitamin containing system nervous central endocrine dermatological